Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04406623
Title Phase 1 Study of SL-172154 (SIRPalpha-Fc-CD40L) in Subjects With Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Shattuck Labs, Inc.
Indications

peritoneum cancer

fallopian tube cancer

ovarian cancer

Therapies

SL-172154

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.